The ACTIV-2 Study is testing different medicines to see if they are safe and can help adults with COVID-19. Finding treatments for COVID-19 is important because the virus is spreading quickly all over the world and can cause serious sickness and even death.
Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.
Study type: Interventional (Clinical Trial)
Estimated Enrollment: 2000 participants
Actual Study Start Date: August 19, 2020
Estimated Study Completion Date: February 2021
Researchers want to see if the medicines are:
The ACTIV-2 Study is for adults 18 years and older who:
The study lasts about 6 months. You will have in person visits to check on the status of your health. Most of these visits will happen during the first month of the study. You will also have phone calls or video chats from your home with a researcher.
If you agree to be in the study, you will give your permission by signing an informed consent form.
The informed consent contains all of the important information about the study. Ask questions and make sure you understand the study before signing the form.
You will answer some questions to make sure the study is right for you.
The screening may take place during a visit with a researcher, over the phone, or by video chat. If you meet with the researcher, you may also have a checkup.
You will meet with a researcher for tests and to be placed in a treatment group.
You will have some tests to check your heart, lungs, and general health, as well as a blood test and a nose swab. You will be placed in a treatment group by chance, like flipping a coin.
Take the medicine exactly as the researcher explains to you. You will also have up to 7 visits with a researcher for tests and up to 5 phone calls from home with the researcher or nurse. Most of the visits happen during the first 28 days of the study.
Have you been diagnosed with COVID-19 in the past week? If so, you may be a good fit to join the ACTIV-2 Study and help us find a treatment for COVID-19! Call to learn more (877) 345-8813. Being in the study is completely voluntary. You can leave the study at any time.
For general questions about COVID-19 clinical trials, please email [email protected]